A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer

Neoplasma

Volumn 55, Issue 3, 2008, Pages 261-265

  Mazurek, A ^a   Kuc P ^a   Mazurek Wadolkowska E ^a   Laudanski T ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Endometrial cancer; p 53; Thymidine phosphorylase

Indexed keywords

EOSIN; HEMATOXYLIN; PROTEIN P53; THYMIDINE PHOSPHORYLASE; TUMOR MARKER;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALPINGOOOPHORECTOMY; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

AGED; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 49049106405     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. MAZUREK A, TELEGO M, PIERZYŃSKI P, et al. Angiogenesis in endometrial cancer. Neoplasma 1998; 45: 360-364
2. SALVESEN H, IVERSEN O, AKSLEN L. Independent prognostic importance of microvessel density in endometrial carcinoma. Br J Cancer 1998; 77: 1140-1144. (Pubitemid 28116287)
3. SUH D. Understanding Angiogenesis and its Clinical Aplications. Annals of Clinical and Laboratory Science. 2000; 30: 235-245
4. GIATROMANOLAKI A, SIVRIDIS E, KOUKOURAKIS et al. Intratumoral Angiogenesis: A New Prognostic Indicator for Stage I Endometrial Adenocarcinomas? Oncol Res 1999; 11: 205-212
5. NIKLIŃSKA W, BURZYKOWSKI T, CHYCZEWSKI L, et al. Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis. J Lung Cancer 2001; 34(2): 59-64.
6. TSUKAGOSHI S, SAGA Y, SUZUKI N, et al. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Int J Oncology 2003; 22: 961-967.
7. FUJIWAKI R, HATA K, IIDA K, et al. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. Gynecol Oncol 1998; 68: 247-252.
8. FUJIWAKI R, HATA K, NAKAYAMA K, et al. Thymidylate synthase expression in epithelial ovarian cancer: relationship with thymidine phosphorylase expression and prognosis. Oncology 2000; 59: 152-157
9. HATA K, FUJIWAKI R, NAKAYAMA K, et al. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor. Anticancer Res 2000; 20(5C): 3941-3949 (Pubitemid 32002302)
10. HATA K, KAMIKAWA T, ARAO S, et al. Expression of thymidine phosphorylase gene in epithelial ovarian cancer. Br J Cancer 1999; 79 (11/12): 1848-1854. (Pubitemid 29132314)
11. FUJIWAKI R, IIDA K, KANASAKI H, et al. Cyclooxygenase-2 expression in endometrial cancer:correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Human Pathol 2002; 33: 213-219.
12. TAKEBAYASHI Y, MIYADARA K, AKIYAMA S, et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996; 87: 288-295. (Pubitemid 26117060)
13. HAN JY, HONG EK, LEE SY, et al. Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer. J Clin Pathol 2005; 58: 650-654
14. YAMASHITA J, OGAWA M, ABE M, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase concentrations differ in small cell and non-small cell lung cancer. Chest 1999; 116: 206-211 (Pubitemid 29340284)
15. HATA K, FUJIWAKI R, MAEDE Y, et al. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity. Gynecol Oncol 2000; 77: 26-34. (Pubitemid 30217301)
16. WOJCIK-KROWIRANDA K, MISZCZAK-ZABORSKA E, GOTTWALD L, et al. Thymidine phosphorylase activity and neo-angiogenesis in ovarian cancer. Ginekol Pol 2003; 74: 911-917
17. KATAOKA A, YUASA T, KAGEYAMA S, et al. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer. Oncol Rep 2005; 13: 597-600.
18. KIKUNO N, YOSHINO T, URAKAMI S, et al. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer. Anticancer Res 2003; 23: 1305-1312 (Pubitemid 36754092)
19. ABULAFIA O, TRIEST W, SHERER D, et al. Angiogenesis in Endometrial Hyperplasia and Stage I Endometrial Carcinoma. Obstet Gynecol 1995; 86: 479-485
20. GOODHEART M, VASEF M, SOOD A, et al. Ovarian cancer p53 mutation is associated with tumor microvessel density. J Gynecol Oncol 2002; 86: 85-90. (Pubitemid 34757056)
21. BEBENEK M, BAR JK, HARLOZINSKA A, et al. Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement. Anticancer Res 1998; 18: 619-623
22. DI LEO A, CHAN S, PAESMANS M, et al. HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. Breast Cancer Res Treat 2004; 86: 197-206. (Pubitemid 39070962)
23. LINSALATA M, NOTARNICOLA M, CARUSO et al. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma. Scand J Gastroenterol 2004; 39: 470-477 (Pubitemid 38626628)
24. BRAMBILLA E, BRAMBILLA C. p53 and lung cancer. Pathol Biol (Paris) 1997; 45: 852-863
25. HAYAKAWA K, MITSUHASHI N, HASEGAWA et al. The prognostic significance of immunohistochemically detected p53 protein expression in non-small cell lung cancer treated with radiation therapy. Anticancer Res 1998; 18: 3685-3688
26. MANGIONI C, DE PALO G, MARUBINI E, et al. Surgical pathologic staging in apparent stage I endometrial carcinoma. Int J Gynecol Cancer 1993; 3: 373-384. (Pubitemid 23336316)
27. HETZEL DJ, WILSON TO, KEENEY GL, et al.. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol 1992; 47 (2): 179-185
28. SAEGUSA M, KAMATA Y, ISONO M, et al. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone-receptor immunoreactivity in endometrial carcinoma. J Pathol 1996; 180: 275-282
29. SAKURAGI N, OHKOUCHI T, HAREYAMA H, et al. Bcl-2 expression and prognosis of patients with endometrial carcinoma. Int J Cancer 1998; 79: 153-158 (Pubitemid 28201687)
30. PISANI AL, BARBUTO DA, CHEN D, et al. HER-2/neu, p-53 and DNA analyses as prognosticators for survival in endometrial carcinoma. Obstst. Gynecol. 1995; 85: 729-734
31. TROJAN J, JOHNSON T, RUDIN S, et al. Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci USA 1994; 91: 6088-6092 (Pubitemid 24188288)
32. JECZEN R, SKOMRA D, CYBULSKI M, et al. P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome. Clin Exp Metastasis 2007; 24: 503-511
33. RAGNI N, FERRERO S, PREFUMO F, et al. The association between p53 expression, stage and histological features in endometrial cancer. Eur J Obstet Gynecol Reprod Biol 2005; 123: 111-116 (Pubitemid 41563104)
34. YAMAZAWA K, SHIMADA H, HIRAI M, et al. Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer. Am J Obstet Gynecol 2007; 197: 505 e1-7.
35. KAUKAURAKIS MI, GIETROMANOLAKI A, O'BYRNE K, et al. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 1997; 75: 477-481. (Pubitemid 27085285)
36. MAEDA K, CHUNG Y, OGAWA S, et al. Thymidine phosphorylase/platelet- derived endothelial cell growth factor exprssion associated with hepatic metastasis in gastric carconoma. Br J Cancer 1996; 73: 884-888.
37. TANAKA Y, KOBAYASHI H, SUZUKI M, et al. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Hum Pathol 2002; 33: 1105-1113
38. FOX S, WESTWOOD M, MAGHADDAM A, et al. The antigenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is upregulated in breast cancer epithelium and endothelim. Br J Cancer 1996; 73: 275-280.